COVID-19 in children treated with immunosuppressive medication for kidney diseases

BACKGROUND: Children are recognised as at lower risk of severe COVID-19 compared with adults, but the impact of immunosuppression is yet to be determined. This study aims to describe the clinical course of COVID-19 in children with kidney disease taking immunosuppressive medication and to assess dis...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Arch Dis Child
Main Authors: Marlais, Matko, Wlodkowski, Tanja, Al-Akash, Samhar, Ananin, Petr, Bandi, Varun Kumar, Baudouin, Veronique, Boyer, Olivia, Vásquez, Luciola, Govindan, Sukanya, Hooman, Nakysa, Ijaz, Iftikhar, Loza, Reyner, Melgosa, Marta, Pande, Nivedita, Pape, Lars, Saha, Anshuman, Samsonov, Dmitry, Schreuder, Michiel F, Sharma, Jyoti, Siddiqui, Sahar, Sinha, Rajiv, Stewart, Heather, Tasic, Velibor, Tönshoff, Burkhard, Twombley, Katherine, Upadhyay, Kiran, Vivarelli, Marina, Weaver, Donald J, Woroniecki, Robert, Schaefer, Franz, Tullus, Kjell
Formato: Artigo
Idioma:Inglês
Publicado em: BMJ Publishing Group 2021
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7754669/
https://ncbi.nlm.nih.gov/pubmed/33355203
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/archdischild-2020-320616
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados